Profile data is unavailable for this security.
About the company
Qingdao Haier Biomedical Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of biomedical low-temperature storage products. The Company's main businesses include: providing biomedical low-temperature storage solutions covering the whole temperature range for scenarios such as sample safety, drug and reagent safety, vaccine safety and blood safety, as well as automatic, intelligent and comprehensive upgrading based on user needs, and providing integrated solutions for Internet of Thing (IoT) scenarios covering a variety of biosafety products. The Company's products are sold to domestic and overseas markets.
- Revenue in CNY (TTM)2.28bn
- Net income in CNY406.15m
- Incorporated2005
- Employees2.64k
- LocationQingdao Haier Biomedical Co LtdNo. 280 Fengyuan Road, High-tech ZoneQINGDAO 266000ChinaCHN
- Phone+86 53 288935566
- Fax+86 53 288936010
- Websitehttps://www.haierbiomedical.com/
More ▼
Mergers & acquisitions
| Acquired company | 688139:SHH since announced | Transaction value |
|---|---|---|
| Shanghai Chaolian Technology Co Ltd | -39.65% | 6.03m |
Data delayed at least 15 minutes, as of Apr 18 2024 08:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Farsoon Technologies Co Ltd | 629.70m | 136.98m | 10.23bn | 687.00 | 74.71 | 5.23 | -- | 16.25 | 0.3307 | 0.3307 | 1.52 | 4.73 | 0.3685 | 1.21 | 2.72 | 916,592.40 | 8.02 | -- | 9.39 | -- | 50.27 | -- | 21.75 | -- | 6.22 | -- | 0.0217 | -- | 32.74 | -- | 32.24 | -- | -- | -- |
| Shanghai GenTech Co Ltd | 4.01bn | 415.10m | 11.06bn | 1.65k | 25.96 | 3.55 | -- | 2.76 | 1.50 | 1.50 | 14.52 | 10.98 | 0.5353 | 0.9301 | 3.15 | 2,436,344.00 | 5.92 | 5.64 | 14.56 | 11.92 | 26.35 | 26.55 | 11.05 | 9.94 | 0.5916 | -- | 0.2901 | 13.56 | 41.78 | 33.02 | 55.15 | 46.23 | 77.88 | -- |
| Qingdao Haier Biomedical Co Ltd | 2.28bn | 406.15m | 11.85bn | 2.64k | 28.99 | 2.72 | -- | 5.19 | 1.29 | 1.29 | 7.21 | 13.72 | 0.4069 | 4.93 | 8.41 | 865,378.00 | 7.39 | 11.49 | 9.42 | 15.22 | 49.30 | 49.98 | 18.17 | 25.20 | 2.53 | -- | 0.0295 | 26.53 | -20.36 | 22.07 | -32.41 | 28.94 | 20.64 | -- |
| Shanghai Mechanical & lctrcl ndstry C Lt | 22.09bn | 981.25m | 11.87bn | 4.59k | 13.42 | 0.9629 | -- | 0.5374 | 0.9594 | 0.9594 | 21.60 | 13.38 | 0.5793 | 2.05 | 3.60 | 4,814,498.00 | 4.02 | 4.33 | 11.09 | 12.49 | 15.69 | 16.39 | 6.94 | 6.74 | 1.10 | -- | 0.0165 | 38.87 | -5.30 | 1.00 | 1.88 | -4.65 | -- | 0.00 |
| Jack Technology Co Ltd | 5.48bn | 614.19m | 12.87bn | 6.40k | 20.33 | 2.79 | -- | 2.35 | 1.31 | 1.31 | 11.62 | 9.51 | 0.6601 | 4.79 | 5.11 | 855,576.60 | 7.47 | 6.72 | 13.32 | 11.78 | 28.45 | 26.32 | 11.31 | 8.92 | 0.8588 | -- | 0.2773 | 35.47 | -3.78 | 4.98 | 9.08 | 3.46 | -8.27 | 6.87 |
| Hangzhou Honghua Digi Techngy Stk Co Ltd | 1.34bn | 347.67m | 12.92bn | 941.00 | 36.80 | 4.43 | -- | 9.62 | 2.92 | 2.92 | 11.26 | 24.19 | 0.3947 | 1.53 | 3.30 | 1,427,955.00 | 10.52 | 14.72 | 12.52 | 18.05 | 45.19 | 44.88 | 26.65 | 25.65 | 3.09 | -- | 0.0715 | 18.28 | 40.65 | 21.62 | 33.84 | 26.16 | 91.13 | -- |
| Jingjin Equipment Inc | 6.29bn | 1.02bn | 13.39bn | 5.48k | 12.88 | 3.18 | -- | 2.13 | 1.80 | 1.80 | 11.08 | 7.30 | 0.7403 | 1.60 | 7.23 | 1,148,351.00 | 12.04 | 11.41 | 23.71 | 20.58 | 30.83 | 31.30 | 16.26 | 14.71 | 0.681 | -- | 0.0461 | 59.69 | 9.98 | 16.45 | 20.89 | 32.76 | 38.70 | -- |
| Yindu Kitchen Equipment Co Ltd | 2.69bn | 577.98m | 13.68bn | 2.27k | 23.64 | 4.58 | -- | 5.09 | 1.38 | 1.38 | 6.40 | 7.10 | 0.7046 | 1.78 | 10.50 | 1,185,868.00 | 15.16 | 12.82 | 18.77 | 16.13 | 44.54 | 40.99 | 21.52 | 17.81 | 2.28 | -- | 0.1668 | 68.02 | -0.3882 | 12.29 | 13.80 | 15.52 | 21.15 | 37.97 |
Data as of Apr 18 2024. Currency figures normalised to Qingdao Haier Biomedical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
15.79%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Schroder Investment Management North America, Inc.as of 29 Feb 2024 | 12.94m | 4.07% |
| JPMorgan Asset Management (Asia Pacific) Ltd.as of 31 Mar 2024 | 11.53m | 3.63% |
| Schroder Investment Management (Hong Kong) Ltd.as of 31 Dec 2023 | 7.81m | 2.46% |
| Hwabao WP Fund Management Co., Ltd.as of 31 Dec 2023 | 5.21m | 1.64% |
| WCM Investment Management LLCas of 29 Feb 2024 | 3.39m | 1.07% |
| Caitong Securities Asset Management Co., Ltd.as of 30 Jun 2023 | 2.50m | 0.79% |
| Matthews International Capital Management LLCas of 31 Jan 2024 | 2.00m | 0.63% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2023 | 1.80m | 0.57% |
| JPMorgan Asset Management (UK) Ltd.as of 05 Apr 2024 | 1.62m | 0.51% |
| GF Fund Management Co., Ltd.as of 30 Jun 2023 | 1.42m | 0.45% |
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
